Pharma manufacturers lawsuits against payers and benefit managers preferred drugs are on FTC’s radar

July 12, 2021

Availability of new drugs result in U.S. Task Force’s consideration of routine kidney disease screening

May 31, 2022

AstraZeneca Invests $85M in Quell for “One and Done” Cell Therapy to Combat Type 1 Diabetes

June 13, 2023

Must Read

Teva Pens Deal Worth Over $700M to Buy Emalex

April 30, 2026

Top 10 Pharma Companies Leading Innovation in Drug Development (2026)

April 28, 2026

Top 10 Emerging Trends in Life Sciences for 2026

April 28, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Oruka Therapeutics Reports Phase 2a Psoriasis Data Showing 63.5% Skin Clearance with ORKA-001

TIGIT dream fails in phase three, Gilead breaks off its relationship with Arcus

Merck and Eisai Three-Drug Combination Therapy Fails to Meet Survival Endpoints in Phase 3 RCC Trial

Actuate Therapeutics medication increases survival chances in pancreatic cancer trial

Teva Pens Deal Worth Over $700M to Buy Emalex

Lilly Continues Good M&A Run With $2.3B Deal For JAK Inhibitor Biotech Ajax

Amneal to Acquire Kashiv BioSciences in Deal Worth Up to $1.1 Billion

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Top 10 Pharma Companies Leading Innovation in Drug Development (2026)

Top 10 Breakthrough Therapies Shaping the Future of Medicine (2026)

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

How Are Macroeconomic Conditions Impacting Pharma and Biotech Funding?

Tag: FDA taking time to consider Cytokinetics

Heart failure drug by Cytokinetics delayed – FDA wants more time to review

Editor Picks

Pharma manufacturers lawsuits against payers and benefit managers preferred drugs are on FTC’s radar

Availability of new drugs result in U.S. Task Force’s consideration of routine kidney disease screening

AstraZeneca Invests $85M in Quell for “One and Done” Cell Therapy to Combat Type 1 Diabetes

Must Read

Teva Pens Deal Worth Over $700M to Buy Emalex

Top 10 Pharma Companies Leading Innovation in Drug Development (2026)

Top 10 Emerging Trends in Life Sciences for 2026

Hot Topics

About Us

Follow Us